L. Cesana

IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism

M. Roncarolo, A. Lombardo, F. Ciceri, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer

A. Kajaste-Rudnitski, L. Passeri, M. Comi, 2020, Frontiers in Immunology.

Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation

M. Pierotti, T. Negri, S. Pilotti, 2015, Modern Pathology.

Normative data for Lezak’s Tinkertoy test in healthy Italian adults

R. Daini, F. Crippa, L. Cesana, 2016 .

Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.

A. Annoni, C. Gianfrani, R. Troncone, 2023, Journal of autoimmunity.

AKT1 and BRAF mutations in pediatric aggressive fibromatosis

S. Pilotti, A. Ferrari, A. Gronchi, 2016, Cancer medicine.